openPR Logo
Press release

Next Generation Sequencing Market Expected to Witness Huge Growth During the Forecast Period | Leading Key Players: Thermo Fischer Scientific, Pacific Biosciences, Partek, Genomatix Software GmbH, Perkin Elmer, Agilent Technologies, BGI, and Qiagen

11-12-2018 02:45 PM CET | Health & Medicine

Press release from: Market Data Forecast

Next Generation Sequencing Market Expected to Witness Huge

Modern technologies assist in the sequencing of DNA and RNA much more quickly and cheaply than the Sanger sequencing and these have transformed the study of genomics and molecular biology. The arrival of next-generation sequencing technologies has brought noteworthy changes in the sequencing process by providing speed, flexibility and reduced sequencing cost over thousand folds.

Global Next Generation Sequencing Market Size:

According to Market Data Forecast, The Global Next Generation Sequencing Market which was worth USD 3.63 billion by the end of 2018 is poised to reach USD 8.54 billion by 2023 at a CAGR of 18.66%.

The next generation data analysis market is anticipated to see the fastest growth during the forecast period. With an expected increase in the enactment of whole genome sequencing, the following data generated from sequencing projects is predicted to grow harmonically with the number of sequencing projects.

Request for Sample @ https://marketdataforecast.com/market-reports/next-generation-sequencing-market-116/request-sample

Advancements in pre-sequencing and NGS bioinformatics solutions, Rise in growth of personalized medicine and cloud computing, increasing incidences of infectious diseases, growth in global population, and cancer are few factors driving the market growth. In addition, anticipated decrease in the prices of genome sequencing due to development of rapid, high capacity whole genome sequencers by key players is expected to have a positive effect on market penetration rates over the few years. However, the storage and management of data generated by sequencing and its interpretation, high reliability on grants & funding from the government and fall in capital expenditure from academic institutions are few factors hindering the growth of global next generation sequencing market.

Market Segmentation:

The Next Generation Sequencing market is categorized by product (software and services) and by technology. By technology it is sub segmented into targeted re-sequencing, genome sequencing, de novo sequencing, exome sequencing, RNA-Seq, ChIP-Seq and Methyl-Seq. And by application it is sub segmented into diagnostics, drug discovery, biomarker discovery, personalized medicine, and agriculture & animals research. Targeted sequencing accounts for the largest share of the market, however owing to the expected development of whole genome sequencing capabilities, the earlier segment is expected to lose market share by 2022

Each market is further analyzed at a ground level by geography, under Asia-Pacific, North America, Europe, Latin America, and Africa & Middle-East. North America is poised to account for the prime market share of the NGS market, followed by Europe.

Browse Report Brief and TOC @ https://marketdataforecast.com/market-reports/next-generation-sequencing-market-116/

Asia-Pacific region presents significant opportunities for the investors/venture capitalists as the developed markets get saturated. The presence of noteworthy developments in China and Japan for integration of new technologies, and the development of healthcare, R&D and clinical development frameworks of developing economies such as India and Australia have led to the Asia Pacific market to witness rewarding growth throughout the forecast period.

Next Generation Sequencing Market Insights:

1. Japan has the largest share in Asia-Pacific NGS Market which accounts for 38% of the total market in 2018.
2. China is expected to grow at the highest CAGR showing with Y-O-Y Growth Rate between 20.3% to 30.6% range, over the forecast period 2018-2021
3. Whole Targeted Re-Sequencing Technology is the most used technology followed by Transcriptome (RNA-Seq)
4. Based on Application, Drug Discovery & Development has the highest share in the market
5. Academic Institutes & Research Centers has the highest share of 59% followed by Biotech/pharmaceutical companies in 2018.

At present, the next generation sequencing market is amalgamated with a few market players due to an involvement of exceptionally complicated technologies and the low target audience for the systems. The market is dominated by Illumina, which accounted for the largest market share of approximately 70%.

Major Companies Dominating the Global Next Generation Sequencing Market are:

• Thermo Fischer Scientific
• Pacific Biosciences
• Macrogen Inc
• Partek Inc
• Genomatix Software GmbH
• Perkin Elmer inc
• GATC Biotech Ag
• Agilent Technologies Inc
• Biomatters Ltd
• BGI (Beijing Genomics Institute)
• Oxford Nanopore Technologies Ltd
• DNASTAR Inc
• Knome Inc
• Qiagen N.V

Buy Now @ https://marketdataforecast.com/cart/buy-now/next-generation-sequencing-market-116/

Reasons to Purchase this Report:

• Current and future Global Next Generation Sequencing Market outlook in the developed and emerging markets
• Analysis of various perspectives of the market with the help of Porter’s five forces analysis
• Identifying the segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3-month analyst support, along with the Market Estimate sheet (in Excel)

Customize Report @ https://marketdataforecast.com/market-reports/next-generation-sequencing-market-116/customize-report

About Us
Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.

For more information:
Abhishek Shukla
Sales Manager at Market Data Forecast
Email: abhishek@marketdataforecast.com
Tel: +1-888-702-9626
Website: www.marketdataforecast.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Next Generation Sequencing Market Expected to Witness Huge Growth During the Forecast Period | Leading Key Players: Thermo Fischer Scientific, Pacific Biosciences, Partek, Genomatix Software GmbH, Perkin Elmer, Agilent Technologies, BGI, and Qiagen here

News-ID: 1362495 • Views:

More Releases from Market Data Forecast

Personalized Nutrition Market is growing at a brisk pace
Personalized Nutrition Market is growing at a brisk pace
The global personalized nutrition market size is expected to be valued at USD 10.84 thousand units in 2024 and reach USD 21.80 thousand units by 2029, growing at a CAGR of 15.0% from 2024 to 2029. Global Personalized Nutrition Market Report Scope: • Market Size (2029): USD 21.80 thousand units • Market Size (2024): USD 10.84 thousand units • CAGR (2024 to 2029): 15% • Base Year: 2023 • Forecast Period: 2024 to 2029 • Segments
Anticipating the Future of the Antibodies Market
Anticipating the Future of the Antibodies Market
The Antibodies market size is expected to be valued at USD 183.7 billion in 2024 and reach USD 183.7 billion by 2029, growing at a CAGR of 11.31% from 2024 to 2029. Antibodies, also known as immunoglobulins, are Y-shaped proteins the immune system produces in response to foreign substances called antigens. Antibodies are employed in various applications, such as diagnostics, research, and therapeutics, which play a crucial role. Global Antibodies Market Report
The Power of Herbal Medicine in Healthcare Market
The Power of Herbal Medicine in Healthcare Market
The herbal medicine market size is expected to be valued at USD 215.4 billion in 2024 and reach USD USD 305.3 billion by 2029, growing at a CAGR of 7.22% from 2024 to 2029. Herbal medicines, derived from plants or plant parts like leaves, flowers, seeds, roots, and stems, have been utilized across diverse cultures for centuries due to their therapeutic properties. They can be prepared in various forms, such as
Innovative Surge Wearable Medical Devices Market Thrives
Innovative Surge Wearable Medical Devices Market Thrives
The global wearable medical devices market size is expected to be valued at USD 11194 million in 2024 and reach USD 28322 million by 2029, growing at a CAGR of 20.40 % from 2024 to 2029. Wearable medical devices are devices that customers can wear, such as activity trackers and smartwatches. These devices are designed to monitor and collect real-time data on customer health and fitness. Global Wearable Medical Devices Market

All 5 Releases


More Releases for Sequencing

Next Generation Sequencing Market Growth of Technological Advancements in Sequen …
Research Report on Next Generation Sequencing Market providing Global Industry Scenario for 5 years (2019 to 2026) is now available under the Life Sciences Section of Search4Research.com Get Research Sample PDF at https://www.search4research.com/request-sample/113582/ Global Next Generation Sequencing Market Trends, Competitive Analysis and Forecast Report 2018-2026 is an exhaustive study on the present market scenario of the global Next Generation Sequencing industry with a special focus on the United States, Europe,
Metagenomic Sequencing Market Technology Outlook 2027 - 16s Rrna Sequencing, Sho …
Worldwide Metagenomic Sequencing Market Analysis to 2027 is a specialized and in-depth study of the Metagenomic Sequencing Industry with a focus on the global market trend. The report aims to provide an overview of global Metagenomic Sequencing Market with detailed market segmentation by product/application and geography. The global Metagenomic Sequencing Market is expected to witness high growth during the forecast period. Metagenomics, is a field where genomic analysis of microbial DNA
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may
Precision Medicine Market Report 2018: Segmentation by Technology (Genomics, Tra …
Global Precision Medicine market research report provides company profile for Abbott Laboratories, Almac Group, Ltd, Asuragen, Inc., Cepheid Inc, Cetics Healthcare Technologies GmbH, Ge Healthcare, Glaxosmithkline Plc, Intomics A/S., Biocrates Life Sciences Ag, Pfizer Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth
Next Generation Sequencing (NGS) Market, By Technology (Whole Exon Sequencing (W …
The next generation sequencing market is estimated to represent a global market of USD 5,618 million by 2017 with growth rate of 9.1%. Next-generation sequencing (NGS) involves an advanced level of genetic sequencing which is a level above the conventional methods such as capillary electrophoresis-based Sanger sequencing. NGS procedure is a multi-step process where a number of smaller laboratory processes combine to form the whole next-generation sequencing process. This includes
Next Generation Sequencing Market Global Analysis and Forecasts by Service (Geno …
ReportsWeb.com has announced the addition of the “Next Generation Sequencing Market to 2025”, the report classifies the global Next Generation Sequencing Market in a precise manner to offer unearth valuable, accurate and reliable data insights that help organizations to meet their business objectives and enable growth. The next generation market is estimated to account for US$ 26,501.2 Mn by the end of 2025, escalating at a CAGR of 21.1% during the